Top

World Journal of Urology

Published in:

01-01-2019 | Letter to the Editor

A new prognostic model for localized renal cell carcinoma

Author: Sebastiano Buti

Published in: World Journal of Urology | Issue 1/2019

Excerpt

Dear Editor, …

Klatte T, Rossi SH, Stewart GD (2018) Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World J Urol. https://doi.org/10.1007/s00345-018-2309-4 CrossRefPubMedPubMedCentral

Buti S, Puligandla M, Bersanelli M, DiPaola RS, Manola J, Taguchi S, Haas NB (2017) Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population. Ann Oncol 28:2747–2753. https://doi.org/10.1093/annonc/mdx492 CrossRefPubMedPubMedCentral

Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS (2005) Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 174:466–472CrossRef

Passalacqua R, Caminiti C, Buti S, Porta C, Camisa R, Braglia L, Tomasello G, Vaglio A, Labianca R, Rondini E, Sabbatini R, Nastasi G, Artioli F, Prati A, Potenzoni M, Pezzuolo D, Oliva E, Alberici F, Buzio C, POLAR-01 Trial Investigators (2014) Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the italian oncology group for clinical research (GOIRC). J Immunother 37:440–447. https://doi.org/10.1097/CJI.0000000000000055 CrossRefPubMed

Title: A new prognostic model for localized renal cell carcinoma
Author: Sebastiano Buti
Publication date: 01-01-2019
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 1/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-018-2335-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A new prognostic model for localized renal cell carcinoma

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2019

Molecular markers in bladder cancer

Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder

SIU–ICUD consultation on bladder cancer 2018

Alpha-blockers with or without phosphodiesterase type 5 inhibitor for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis

SIU–ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer

Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy